Patent ID: 8231899

Claim:
A quick release pharmaceutical composition for oral administration comprising lornoxicam or a pharmaceutically acceptable salt, complex or prodrug thereof, the composition being in the form of a particulate composition or being based on a particulate composition, wherein either the particles of the particulate composition used in the manufacture of the composition have a mean particle size of at the most 250 micrometers, or at least 50% w/w of the particles of the particulate composition used in the manufacture of the composition pass through a 180 micrometer sieve; wherein the quick release pharmaceutical composition contains the lornoxicam in contact with an alkaline substance in a ratio of one part lornoxicam to up to five parts alkaline substance; and the composition, when tested in accordance with the dissolution method I defined herein employing 0.07 N hydrochloric acid as dissolution medium, releases at least 80% w/w of the lornoxicam within the first 20 minutes of the test.